The Glycine Receptor α4 subunit (GlyR α4) is integral to the function of the glycine receptor, a chloride channel that mediates inhibitory neurotransmission in the central nervous system. This receptor plays a pivotal role in modulating neuronal excitability, thereby influencing a wide array of neurological processes including pain perception, motor control, and synaptic plasticity. The GlyR α4 subunit, specifically, contributes to the receptor's heterogeneity and pharmacological properties, affecting its distribution, localization, and functional dynamics within synaptic and extrasynaptic regions of neurons. As part of the larger GlyR complex, the α4 subunit interacts with ligands, such as glycine, to facilitate chloride ion flow into the neuron, leading to hyperpolarization and a decrease in neuronal firing. This action is essential for the fine-tuning of neural circuits and the maintenance of excitatory-inhibitory balance within the nervous system.
The inhibition of GlyR α4 involves mechanisms that disrupt the normal functioning of the glycine receptor, either by preventing glycine binding, altering receptor conformation, or interfering with ion channel gating. Inhibitors may act directly on the GlyR α4 subunit or indirectly by modulating the receptor's cellular environment, affecting its expression, trafficking, or degradation. Direct inhibition can occur through competitive antagonism, where molecules structurally similar to glycine bind to the receptor's ligand-binding domain without activating it, effectively blocking glycine's action. Non-competitive inhibitors, on the other hand, may bind to allosteric sites, inducing conformational changes that reduce receptor sensitivity to glycine or impair channel opening. Additionally, post-translational modifications such as phosphorylation or ubiquitination of the GlyR α4 subunit can modulate receptor function and its response to inhibitory signals. These inhibitory mechanisms are crucial for understanding the complex regulation of inhibitory neurotransmission and its implications for neural network activity and overall brain function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $66.00 $280.00 $1300.00 | 11 | |
A non-competitive antagonist of the glycine receptor, can block the receptor's chloride channel. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $56.00 $75.00 | 2 | |
A positive allosteric modulator of glycine receptors, can inhibit neuronal signaling at high concentrations. | ||||||
Bilobalide | 33570-04-6 | sc-201061 sc-201061B sc-201061A sc-201061C | 10 mg 25 mg 50 mg 100 mg | $80.00 $160.00 $290.00 $435.00 | 3 | |
A constituent of Ginkgo biloba, known to inhibit glycine receptors. | ||||||
L-701,324 | 142326-59-8 | sc-361224 sc-361224A | 10 mg 50 mg | $158.00 $612.00 | 1 | |
An antagonist of the NMDA receptor, which is influenced by glycine as a co-agonist; thus, can indirectly affect GlyR signaling. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
An endogenous inhibitor of glycine receptors, can influence receptor functioning by binding at an allosteric site. | ||||||
Matrine | 519-02-8 | sc-205741 sc-205741A | 100 mg 500 mg | $242.00 $544.00 | ||
An alkaloid that can modulate various ion channels and receptors, including glycine receptors. | ||||||